Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Cost of Revenue

₹165.91B

TTM · Period ending: · INR

RDY logo

RDY Cost of Revenue

Latest reported₹165.91B INR
RDY TTM Cost of Revenue · INR (₹7.96B → ₹165.91B)
High-resolution chart · PNG

RDY cost of revenue history

Trailing twelve months (TTM) · INR. Each value covers four complete reported quarters.

Dr. Reddy's Laboratories Ltd Common Stock Cost of Revenue — Trailing twelve months (TTM) (INR)
Period endingCost of Revenue (INR)
165,910,289,000
159,314,218,000
154,995,000,000
149,067,000,000
141,549,000,000
135,107,000,000
126,657,000,000
122,068,000,000
90,038,253,991
87,486,253,991
58,467,180,711
56,129,180,711
56,089,327,477
54,406,327,477
54,418,973,850
51,396,973,850
51,435,912,187
48,782,912,187
48,742,901,798
46,915,901,798
46,879,992,194
42,804,992,194
64,014,429,490
41,559,557,145
61,622,127,655
60,778,127,655
58,381,127,655
75,826,000,000
72,518,000,000
70,421,000,000
67,762,000,000
66,663,000,000
66,141,000,000
65,724,000,000
66,630,000,000
65,147,000,000
64,348,000,000
62,453,000,000
61,379,000,000
62,302,000,000
61,963,000,000
62,427,000,000
63,624,000,000
63,614,000,000
63,086,000,000
62,786,000,000
60,190,000,000
58,058,000,000
57,271,000,000
56,370,000,000
58,037,000,000
57,650,000,000
57,048,000,000
55,483,000,000
51,542,000,000
49,099,000,000
46,068,000,000
43,431,000,000
40,042,000,000
37,496,000,000
35,741,000,000
34,430,000,000
32,991,000,000
32,907,000,000
33,838,000,000
33,938,000,000
35,235,000,000
34,877,000,000
33,415,444,000
32,873,444,000
30,003,301,528
28,165,194,677
26,008,260,842
24,458,413,663
24,071,998,027
26,494,235,836
32,173,874,156
34,222,990,040
32,469,693,527
26,665,833,524
17,735,211,093
12,423,811,899
11,130,647,937
10,290,855,201
9,951,558,524
9,770,344,104
9,278,105,939
9,672,417,649
9,692,005,184
9,382,024,609
8,635,037,702
8,155,228,559
7,978,889,967
7,826,950,264
7,960,253,679
7,787,935,502
7,317,370,307
6,866,059,455
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.